
Daewoong expands Middle East presence with Nabota launch in Kuwait
Daewoong Pharmaceutical said it will supply its botulinum toxin Nabota to Kuwait, further cementing its presence in the premium aesthetic market across the Middle East. The company’s latest export marks its fifth market entry in the region and its fourth …